홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

N-(tert-butoxycarbonyl)glycine → 2-{4-(2-({(2-(4-Chlorophenyl)-1,3-thiazol-4-yl)methyl}sulfanyl)-3,5-dicyano-6-(pyrrolidin-1-yl)pyridin-4-yl)phenoxy}ethyl N-(tert-butoxycarbonyl)glycyl-L-leucinate

HRID 1968316
노트
인쇄 미리보기

반응식

HRID 1968316 반응식
[C:1]([O:5][C:6]([NH:8][CH2:9][C:10]([OH:12])=O)=[O:7])([CH3:4])([CH3:3])[CH3:2].Cl.CN(C)CCCN=C=NCC.O.ON1C2C=CC=CC=2N=N1.C(N(CC)C(C)C)(C)C.FC(F)(F)C(O)=O.[NH2:52][C@H:53]([C:58]([O:60][CH2:61][CH2:62][O:63][C:64]1[CH:69]=[CH:68][C:67]([C:70]2[C:75]([C:76]#[N:77])=[C:74]([N:78]3[CH2:82][CH2:81][CH2:80][CH2:79]3)[N:73]=[C:72]([S:83][CH2:84][C:85]3[N:86]=[C:87]([C:90]4[CH:95]=[CH:94][C:93]([Cl:96])=[CH:92][CH:91]=4)[S:88][CH:89]=3)[C:71]=2[C:97]#[N:98])=[CH:66][CH:65]=1)=[O:59])[CH2:54][CH:55]([CH3:57])[CH3:56]>CN(C=O)C.O>[C:1]([O:5][C:6]([NH:8][CH2:9][C:10]([NH:52][C@H:53]([C:58]([O:60][CH2:61][CH2:62][O:63][C:64]1[CH:65]=[CH:66][C:67]([C:70]2[C:75]([C:76]#[N:77])=[C:74]([N:78]3[CH2:82][CH2:81][CH2:80][CH2:79]3)[N:73]=[C:72]([S:83][CH2:84][C:85]3[N:86]=[C:87]([C:90]4[CH:95]=[CH:94][C:93]([Cl:96])=[CH:92][CH:91]=4)[S:88][CH:89]=3)[C:71]=2[C:97]#[N:98])=[CH:68][CH:69]=1)=[O:59])[CH2:54][CH:55]([CH3:56])[CH3:57])=[O:12])=[O:7])([CH3:2])([CH3:3])[CH3:4]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

8

반응물 5

HCID 78288N-(tert-butoxycarbonyl)glycineHCID 81531DiisopropylethylamineHCID 27239391,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochlorideHCID 27960291-Hydroxybenzotriazole hydrateHCID 866438522-{4-(2-({(2-(4-Chlorophenyl)-1,3-thiazol-4-yl)methyl}sulfanyl)-3,5-dicyano-6-(pyrrolidin-1-yl)pyridin-4-yl)phenoxy}ethyl L-leucinate trifluoroacetate

생성물 1

HCID 687629772-{4-(2-({(2-(4-Chlorophenyl)-1,3-thiazol-4-yl)methyl}sulfanyl)-3,5-dicyano-6-(pyrrolidin-1-yl)pyridin-4-yl)phenoxy}ethyl N-(tert-butoxycarbonyl)glycyl-L-leucinate

시약·촉매·용매 2

HCID 962Water용매HCID 6228Dimethylformamide용매

실험 절차

80 mg (0.45 mmol) of N-(tert-butoxycarbonyl)glycine were initially charged in 5.0 ml of DMF, and 95 mg (0.49 mmol) of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride, 95 mg (0.62 mmol) of 1-hydroxy-1H-benzotriazole hydrate and 267 mg (2.06 mmol) of N,N-diisopropylethylamine were added. The mixture was stirred until a clear solution had been obtained. 330 mg (0.41 mmol) of 2-{4-(2-({(2-(4-chlorophenyl)-1,3-thiazol-4-yl)methyl}sulfanyl)-3,5-dicyano-6-(pyrrolidin-1-yl)pyridin-4-yl)phenoxy}ethyl L-leucinate trifluoroacetate were then added, and the mixture was stirred at room temperature for 18 h. The reaction mixture was added to 300 ml of water. The residue formed was filtered off with suction and washed with 20 ml of water. The crude product was suspended in 15 ml of methanol and sonicated in an ultrasonic bath for 5 min. The residue was filtered off with suction and washed with 10 ml of diethyl ether. This gave 0.17 g (47% of theory) of the desired target compound.

후처리

  1. customhad been obtained
  2. stirringthe mixture was stirred at room temperature for 18 h
  3. customThe residue formed
  4. filtrationwas filtered off with suction
  5. washwashed with 20 ml of water
  6. customsonicated in an ultrasonic bath for 5 min
  7. filtrationThe residue was filtered off with suction
  8. washwashed with 10 ml of diethyl ether

출처 및 근거

ORD 기록
ord-0ff1efebc9674a2489ea10236a541cbd
출처 데이터셋
uspto-grants-2013_04
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08420825B2

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트